Engineered CAF-cancer cell hybrid membrane biomimetic dual-targeted integrated platform for multi-dimensional treatment of ovarian cancer
Abstract Background The efficacy of current therapies for ovarian cancer is limited due to the multilevel and complex tumor microenvironment (TME), which induces drug resistance and tumor progression in a single treatment regimen. Additionally, poor targeting and insufficient tissue penetration are...
Saved in:
Main Authors: | Yuwei Yao, Jiarui Zhang, Kexin Huang, Yingying Peng, Shuangshuang Cheng, Shuangge Liu, Ting Zhou, Jinhua Chen, Haojia Li, Yingchao Zhao, Hongbo Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-025-03165-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
by: Zhongsong Zhang, et al.
Published: (2025-01-01) -
Bisecting GlcNAc modification of vesicular GAS6 regulates CAFs activation and breast cancer metastasis
by: Jing Li, et al.
Published: (2025-01-01) -
Spatial profiling of endoplasmic reticulum stress markers in tumor associated cells predicts patient outcomes in pancreatic cancer
by: Georgia Porter, et al.
Published: (2025-02-01) -
Immunotherapy in Recurrent Ovarian Cancer
by: Keyao Chen, et al.
Published: (2025-01-01) -
Engineered bacterial membrane biomimetic covalent organic framework as nano-immunopotentiator for cancer immunotherapy
by: Qi-Chao Yang, et al.
Published: (2025-05-01)